160 related articles for article (PubMed ID: 10994656)
1. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients.
Martin BC; Ricci JF; Kotzan JA; Lang K; Menzin J
Alzheimer Dis Assoc Disord; 2000; 14(3):151-9. PubMed ID: 10994656
[TBL] [Abstract][Full Text] [Related]
2. Incremental dementia-related expenditures in a medicaid population.
Bharmal MF; Dedhiya S; Craig BA; Weiner M; Rosenman M; Sands LP; Modi A; Doebbeling C; Thomas J
Am J Geriatr Psychiatry; 2012 Jan; 20(1):73-83. PubMed ID: 22183012
[TBL] [Abstract][Full Text] [Related]
3. The economic cost of Alzheimer's disease and related dementias to the California Medicaid program ("Medi-Cal") in 1995.
Menzin J; Lang K; Friedman M; Neumann P; Cummings JL
Am J Geriatr Psychiatry; 1999; 7(4):300-8. PubMed ID: 10521162
[TBL] [Abstract][Full Text] [Related]
4. Medicare and medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients.
Bartels SJ; Clark RE; Peacock WJ; Dums AR; Pratt SI
Am J Geriatr Psychiatry; 2003; 11(6):648-57. PubMed ID: 14609805
[TBL] [Abstract][Full Text] [Related]
5. Direct medical expenditures associated with Alzheimer's and related dementias (ADRD) in a nationally representative sample of older adults - an excess cost approach.
Deb A; Sambamoorthi U; Thornton JD; Schreurs B; Innes K
Aging Ment Health; 2018 May; 22(5):619-624. PubMed ID: 28282733
[TBL] [Abstract][Full Text] [Related]
6. Current and future forecasts of service use and expenditures of Medicaid-eligible schizophrenia patients in the state of Georgia.
Miller LS; Martin BC
Schizophr Bull; 2004; 30(4):983-95. PubMed ID: 15954202
[TBL] [Abstract][Full Text] [Related]
7. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use.
Bynum JP; Rabins PV; Weller W; Niefeld M; Anderson GF; Wu AW
J Am Geriatr Soc; 2004 Feb; 52(2):187-94. PubMed ID: 14728626
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal analysis of the lifetime cost of dementia.
Yang Z; Zhang K; Lin PJ; Clevenger C; Atherly A
Health Serv Res; 2012 Aug; 47(4):1660-78. PubMed ID: 22171532
[TBL] [Abstract][Full Text] [Related]
9. Comparison of resource utilization for Medicaid dementia patients using nursing homes versus home and community based waivers for long-term care.
Sands LP; Xu H; Weiner M; Rosenman MB; Craig BA; Thomas J
Med Care; 2008 Apr; 46(4):449-53. PubMed ID: 18362827
[TBL] [Abstract][Full Text] [Related]
10. Economic impact of a Medicaid population health management program.
Rust G; Strothers H; Miller WJ; McLaren S; Moore B; Sambamoorthi U
Popul Health Manag; 2011 Oct; 14(5):215-22. PubMed ID: 21506728
[TBL] [Abstract][Full Text] [Related]
11. Cost of atopic dermatitis and eczema in the United States.
Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Stevens SR; Whitaker-Worth DL; Cheng JW; Tong KB
J Am Acad Dermatol; 2002 Mar; 46(3):361-70. PubMed ID: 11862170
[TBL] [Abstract][Full Text] [Related]
12. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
[TBL] [Abstract][Full Text] [Related]
13. Mental illness, traumatic brain injury, and medicaid expenditures.
Wei W; Sambamoorthi U; Crystal S; Findley PA
Arch Phys Med Rehabil; 2005 May; 86(5):905-11. PubMed ID: 15895335
[TBL] [Abstract][Full Text] [Related]
14. Government expenditures at the end of life for short- and long-stay nursing home residents: differences by hospice enrollment status.
Miller SC; Intrator O; Gozalo P; Roy J; Barber J; Mor V
J Am Geriatr Soc; 2004 Aug; 52(8):1284-92. PubMed ID: 15271115
[TBL] [Abstract][Full Text] [Related]
15. Medicaid recipients in intermediate care facilities for the mentally retarded.
Burwell B; Clauser S; Hall MJ; Simon J
Health Care Financ Rev; 1987; 8(3):1-12. PubMed ID: 10312112
[TBL] [Abstract][Full Text] [Related]
16. The economic burden of schizophrenia in the United States in 2002.
Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J
J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of osteoporosis-related fractures in Medicaid.
Rousculp MD; Long SR; Wang S; Schoenfeld MJ; Meadows ES
Value Health; 2007; 10(2):144-52. PubMed ID: 17391423
[TBL] [Abstract][Full Text] [Related]
18. Medicaid Contributes Substantial Costs to Dementia Care in an Ethnically Diverse Community.
Zhu CW; Ornstein KA; Cosentino S; Gu Y; Andrews H; Stern Y
J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1527-1537. PubMed ID: 31425587
[TBL] [Abstract][Full Text] [Related]
19. Isolating the cost of osteoporosis-related fracture for postmenopausal women. A population-based study.
Martin BC; Chisholm MA; Kotzan JA
Gerontology; 2001; 47(1):21-9. PubMed ID: 11244288
[TBL] [Abstract][Full Text] [Related]
20. The cost of institutional care in Alzheimer's disease: nursing home and hospital use in a prospective cohort.
Welch HG; Walsh JS; Larson EB
J Am Geriatr Soc; 1992 Mar; 40(3):221-4. PubMed ID: 1538039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
